NEW YORK (GenomeWeb News) – Exact Sciences today reported flat revenues year over year for its fourth quarter, matching the consensus analyst estimate on the top line and beating it on the bottom line.

The Madison, Wis.-based molecular diagnostics company took in $1.0 million in revenues for the three months ended Dec. 31, 2013, the same as a year ago. Revenues for Q4 2013 and the year-ago period derived from licensing fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.